drugset / Trial / NCT03616236
Buprenorphine for Probationers and Parolees: Bridging the Gap Into Treatment
RandomizedParallel-groupOpen-labelTreatment
Summary
This five-year study will evaluate the effectiveness of the administration of buprenorphine bridge treatment (BBT) to probationers and parolees compared to treatment as usual (TAU), which consists of referral to a community buprenorphine treatment program.
Timeline
- Start
- 2022-07-01
- Primary completion
- 2026-08-31
- Completion
- 2026-12-30
Outcome
Outcome not reported
Stopped (Enrollment): “Unable to recruit from study sites.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buprenorphine | Other / unclassified | — | — |
| Background | Naloxone | Small molecule | — | — |